About the project
FLAVIVACCINE develops a novel mosquito saliva-targeted vaccine candidate that protects against different flaviviruses and is ready for clinical evaluation by building upon an experimentally validated proof-of-concept.
The pan-flavivirus will have short- and long-term impact on the EU ability to combat epidemic and pandemic viral threats, and protect communities and citizens in the EU and around the world.
Our Role
We lead the Communication, Dissemination and Exploitation activities.
